Pierre Fabre Medicament Sas
General
Total Cases12
Active Cases--
Patents207
Ratings
Experience
Grade
Trend
DCT
L1
A
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 11/25/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,338,489 B2; 8,987,262 B2. (Attachments: # [1] Consent Judgment)(ceg) (Entered: 11/25/2024) | |
| 11/25/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,338,489 B2; 8,987,262 B2. (Attachments: # [1] Consent Judgment)(ceg) (Entered: 11/25/2024) | |
| 11/25/24 | CONSENT JUDGMENT between Plaintiffs Pierre Fabre and Defendant Annora Pharma Private Limited. (*CASE CLOSED). Signed by Judge Jennifer L. Hall on 11/25/2024. (ceg) (Entered: 11/25/2024) | |
| 11/25/24 | CONSENT JUDGMENT between Plaintiffs Pierre Fabre and Defendant Annora Pharma Private Limited. (*CASE CLOSED). Signed by Judge Jennifer L. Hall on 11/25/2024. (ceg) (Entered: 11/25/2024) | |
| 11/21/24 | PROPOSED CONSENT JUDGMENT by Pierre Fabre Pharmaceuticals, Inc., Pierre Fabre Medicament SAS, Universite de Bordeaux, Centre Hospitalier Universitaire de Bordeaux. (Simmons, John) (Entered: 11/21/2024) | |
| 11/21/24 | PROPOSED CONSENT JUDGMENT by Pierre Fabre Pharmaceuticals, Inc., Pierre Fabre Medicament SAS, Universite de Bordeaux, Centre Hospitalier Universitaire de Bordeaux. (Simmons, John) (Entered: 11/21/2024) | |
| 11/15/24 | SO ORDERED, re [150] Stipulation and Order to Extend Post-Trial Briefing. (*Resetting Post Trial Briefing Schedule: Proposed Findings of Fact and Conclusions of Law due 11/21/2024; Responsive Filings due 12/6/2024). Signed by Judge Jennifer L. Hall on 11/15/2024. (ceg) (Entered: 11/15/2024) | |
| 11/15/24 | SO ORDERED, re [150] Stipulation and Order to Extend Post-Trial Briefing. (*Resetting Post Trial Briefing Schedule: Proposed Findings of Fact and Conclusions of Law due 11/21/2024; Responsive Filings due 12/6/2024). Signed by Judge Jennifer L. Hall on 11/15/2024. (ceg) (Entered: 11/15/2024) | |
| 11/13/24 | STIPULATION TO EXTEND TIME of Post-Trial Briefing to Nov. 21, 2024 (Proposed Findings of Facts and Conclusions of Law) & Dec. 6, 2024 (Responses to Proposed Findings of Facts and Conclusions of Law) - filed by Pierre Fabre Pharmaceuticals, Inc., Pierre Fabre Medicament SAS, Universite de Bordeaux, Centre Hospitalier Universitaire de Bordeaux. (Simmons, John) (Entered: 11/13/2024) | |
| 11/13/24 | STIPULATION TO EXTEND TIME of Post-Trial Briefing to Nov. 21, 2024 (Proposed Findings of Facts and Conclusions of Law) & Dec. 6, 2024 (Responses to Proposed Findings of Facts and Conclusions of Law) - filed by Pierre Fabre Pharmaceuticals, Inc., Pierre Fabre Medicament SAS, Universite de Bordeaux, Centre Hospitalier Universitaire de Bordeaux. (Simmons, John) (Entered: 11/13/2024) |